Global Sevoflurane, Isoflurane and Desflurane Market Growth 2023-2029

Global Sevoflurane, Isoflurane and Desflurane Market Growth 2023-2029

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.

Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.

Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.

LPI (LP Information)' newest research report, the “Sevoflurane, Isoflurane and Desflurane Industry Forecast” looks at past sales and reviews total world Sevoflurane, Isoflurane and Desflurane sales in 2022, providing a comprehensive analysis by region and market sector of projected Sevoflurane, Isoflurane and Desflurane sales for 2023 through 2029. With Sevoflurane, Isoflurane and Desflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane, Isoflurane and Desflurane industry.

This Insight Report provides a comprehensive analysis of the global Sevoflurane, Isoflurane and Desflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane, Isoflurane and Desflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sevoflurane, Isoflurane and Desflurane market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane, Isoflurane and Desflurane and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane, Isoflurane and Desflurane.

The global Sevoflurane, Isoflurane and Desflurane market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.

This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane, Isoflurane and Desflurane market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Sevoflurane
Isoflurane
Desflurane

Segmentation by application
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Baxter
Lunan Pharmaceutical Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sevoflurane, Isoflurane and Desflurane market?

What factors are driving Sevoflurane, Isoflurane and Desflurane market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sevoflurane, Isoflurane and Desflurane market opportunities vary by end market size?

How does Sevoflurane, Isoflurane and Desflurane break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.